VivoSeq
Dermatology

Genital Warts

0

Pipeline Programs↗

1

Active Trials↗

4

Companies Involved↗

Genital Warts is an early-stage landscape with 0 programs across 4 companies. The most active players are Graceway Pharmaceuticals, LLC, Gilead, MEDA Pharma GmbH & Co. KG.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

78/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

G

Graceway Pharmaceuticals, LLC

0 programs

PreclinicalGilead logo

Gilead

0 programs

PreclinicalM

MEDA Pharma GmbH & Co. KG

0 programs

PreclinicalNovartis logo

Novartis

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

12

clinical trials

Completed7 · 58%
Unknown status2 · 17%
Terminated2 · 17%
Not yet recruiting1 · 8%

Clinical Trials

Trial Activity

12 trials

Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts
Not yet recruiting·SSheikh Zayed Medical College·Phase 2·NCT06809777·96 enrolled
Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts
Completed·Gilead logoGilead·Phase 1·NCT00499967·202 enrolled
Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
Completed·GGraceway Pharmaceuticals, LLC·Phase 3·NCT00674739·470 enrolled
Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment
Completed·IIcahn School of Medicine at Mount Sinai·N/A·NCT02147353·42 enrolled
Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts
Completed·MMEDA Pharma GmbH & Co. KG·Phase 4·NCT00189293·128 enrolled
Low Dose Cyclophosphamide Treats Genital Warts
Completed·HHuazhong University of Science and Technology·Phase 3·NCT00999986·104 enrolled
Efficacy and Tolerability of Topical LFX453 for External Genital Warts
Completed·Novartis logoNovartis·Phase 2·NCT02482428·88 enrolled
Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
Completed·GGraceway Pharmaceuticals, LLC·Phase 3·NCT00735462·511 enrolled
A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
Terminated·UUniversity of British Columbia·Phase 4·NCT01468636·50 enrolled
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital Warts
Terminated·VViroXis Corporation·Phase 2·NCT03158974·12 enrolled
Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study
Unknown status·CCentro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri·Phase 3·NCT03901690·102 enrolled
Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts
Unknown status·—·Phase 3·NCT03853785·45 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)